These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15727886)

  • 1. Celecoxib improves the efficiency of the locomotor mechanism in patients with knee osteoarthritis. A randomised, placebo, double-blind and cross-over trial.
    Detrembleur C; De Nayer J; van den Hecke A
    Osteoarthritis Cartilage; 2005 Mar; 13(3):206-10. PubMed ID: 15727886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
    Tannenbaum H; Berenbaum F; Reginster JY; Zacher J; Robinson J; Poor G; Bliddal H; Uebelhart D; Adami S; Navarro F; Lee A; Moore A; Gimona A
    Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
    Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS
    Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.
    Rother M; Lavins BJ; Kneer W; Lehnhardt K; Seidel EJ; Mazgareanu S
    Ann Rheum Dis; 2007 Sep; 66(9):1178-83. PubMed ID: 17363401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.
    Pincus T; Koch G; Lei H; Mangal B; Sokka T; Moskowitz R; Wolfe F; Gibofsky A; Simon L; Zlotnick S; Fort JG
    Ann Rheum Dis; 2004 Aug; 63(8):931-9. PubMed ID: 15082468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of gait parameters to the effects of anti-inflammatory and opioid treatments in knee osteoarthritis patients.
    Boyer KA; Angst MS; Asay J; Giori NJ; Andriacchi TP
    J Orthop Res; 2012 Jul; 30(7):1118-24. PubMed ID: 22179861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495].
    Najm WI; Reinsch S; Hoehler F; Tobis JS; Harvey PW
    BMC Musculoskelet Disord; 2004 Feb; 5():6. PubMed ID: 15102339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
    Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
    Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
    Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC
    J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
    Reuben SS; Buvenandran A; Katz B; Kroin JS
    Anesth Analg; 2008 Apr; 106(4):1258-64, table of contents. PubMed ID: 18349203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
    Lehmann R; Brzosko M; Kopsa P; Nischik R; Kreisse A; Thurston H; Litschig S; Sloan VS
    Curr Med Res Opin; 2005 Apr; 21(4):517-26. PubMed ID: 15899100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
    Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeatability of gait analysis for measuring knee osteoarthritis pain in patients with severe chronic pain.
    Asay JL; Boyer KA; Andriacchi TP
    J Orthop Res; 2013 Jul; 31(7):1007-12. PubMed ID: 23508626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
    Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial.
    Gordo AC; Walker C; Armada B; Zhou D
    J Int Med Res; 2017 Feb; 45(1):59-74. PubMed ID: 28222627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.
    Conaghan PG; Dickson J; Bolten W; Cevc G; Rother M
    Rheumatology (Oxford); 2013 Jul; 52(7):1303-12. PubMed ID: 23542612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
    Bingham CO; Smugar SS; Wang H; Peloso PM; Gammaitoni A
    Pain Med; 2011 Mar; 12(3):352-61. PubMed ID: 21332932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
    Bingham CO; Bird SR; Smugar SS; Xu X; Tershakovec AM
    Osteoarthritis Cartilage; 2008 Nov; 16(11):1289-93. PubMed ID: 18514551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial.
    Chopra A; Saluja M; Tillu G; Sarmukkaddam S; Venugopalan A; Narsimulu G; Handa R; Sumantran V; Raut A; Bichile L; Joshi K; Patwardhan B
    Rheumatology (Oxford); 2013 Aug; 52(8):1408-17. PubMed ID: 23365148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.